{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:42:43Z","timestamp":1762508563474,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2018YFC0116900"],"award-info":[{"award-number":["2018YFC0116900"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["CIFMS 2016-I2M-2-004"],"award-info":[{"award-number":["CIFMS 2016-I2M-2-004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Regional citrate anticoagulation (RCA) is an important local anticoagulation method during bedside continuous renal replacement therapy. To improve patient safety and achieve computer assisted dose monitoring and control, we took intensive care units patients into cohort and aiming at developing a data-driven machine learning model to give early warning of citric acid overdose and provide adjustment suggestions on citrate pumping rate and 10% calcium gluconate input rate for RCA treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patient age, gender, pumped citric acid dose value, 5% NaHCO<jats:sub>3<\/jats:sub>solvent, replacement fluid solvent, body temperature value, and replacement fluid PH value as clinical features, models attempted to classify patients who received regional citrate anticoagulation into correct outcome category. Four models, Adaboost, XGBoost, support vector machine (SVM) and shallow neural network, were compared on the performance of predicting outcomes. Prediction results were evaluated using accuracy, precision, recall and F1-score.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>For classifying patients at the early stages of citric acid treatment, the accuracy of neutral networks model is higher than Adaboost, XGBoost and SVM, the F1-score of shallow neutral networks (90.77%) is overall outperformed than other models (88.40%, 82.17% and 88.96% for Adaboost, XGBoost and SVM). Extended experiment and validation were further conducted using the MIMIC-III database, the F1-scores for shallow neutral networks, Adaboost, XGBoost and SVM are 80.00%, 80.46%, 80.37% and 78.90%, the AUCs are 0.8638, 0.8086, 0.8466 and 0.7919 respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The results of this study demonstrated the feasibility and performance of machine learning methods for monitoring and adjusting local regional citrate anticoagulation, and further provide decision-making recommendations to clinicians point-of-care.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12911-021-01489-8","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T09:03:36Z","timestamp":1627635816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Early warning of citric acid overdose and timely adjustment of regional citrate anticoagulation based on machine learning methods"],"prefix":"10.1186","volume":"21","author":[{"given":"Huan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longxiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huizhen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4215-5839","authenticated-orcid":false,"given":"Weiguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,30]]},"reference":[{"issue":"9","key":"1489_CR1","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","volume":"33","author":"S Uchino","year":"2007","unstructured":"Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med. 2007;33(9):1563\u201370.","journal-title":"Intensive Care Med"},{"issue":"4","key":"1489_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/cc5937","volume":"11","author":"M Joannidis","year":"2007","unstructured":"Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11(4):218.","journal-title":"Crit Care"},{"issue":"5","key":"1489_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/ki.1990.300","volume":"38","author":"RL Mehta","year":"1990","unstructured":"Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int. 1990;38(5):976\u201381.","journal-title":"Kidney Int"},{"issue":"16","key":"1489_CR4","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/jama.2020.18618","volume":"324","author":"A Zarbock","year":"2020","unstructured":"Zarbock A, K\u00fcllmar M, Kindgen-Milles D, Wempe C, Gerss J, Brandenburger T, Dimski T, Tyczynski B, Jahn M, M\u00fclling N. Effect of regional citrate anticoagulation vs systemic heparin anticoagulation during continuous kidney replacement therapy on dialysis filter life span and mortality among critically ill patients with acute kidney injury: a randomized clinical trial. JAMA. 2020;324(16):1629\u201339.","journal-title":"JAMA"},{"issue":"1","key":"1489_CR5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/cc9358","volume":"15","author":"HM Oudemans-van Straaten","year":"2011","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care. 2011;15(1):202.","journal-title":"Crit Care"},{"issue":"4","key":"1489_CR6","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120(4):c179\u201384.","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"1489_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/MCC.0000000000000547","volume":"24","author":"D Kindgen-Milles","year":"2018","unstructured":"Kindgen-Milles D, Brandenburger T, Dimski T. Regional citrate anticoagulation for continuous renal replacement therapy. Curr Opin Crit Care. 2018;24(6):450\u20134.","journal-title":"Curr Opin Crit Care"},{"issue":"5","key":"1489_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/S0272-6386(00)70248-4","volume":"35","author":"DJ Kutsogiannis","year":"2000","unstructured":"Kutsogiannis DJ, Mayers I, Chin WDN, Gibney RN. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis. 2000;35(5):802\u201311.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1489_CR9","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1007\/s00134-003-1801-4","volume":"29","author":"M Dorval","year":"2003","unstructured":"Dorval M, Madore F, Courteau S, Leblanc M. A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med. 2003;29(7):1186\u20139.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1489_CR10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/0391398819894595","volume":"43","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Zhuang F, Fan Q, Yu W, Ding F. The possibility of using effluent ionized calcium to assess regional citrate anticoagulation in continuous renal replacement therapy. Int J Artif Organs. 2020;43(6):379\u201384.","journal-title":"Int J Artif Organs"},{"issue":"6","key":"1489_CR11","first-page":"819","volume":"17","author":"L Gabutti","year":"2004","unstructured":"Gabutti L, Ferrari N, Mombelli G, Keller F, Marone C. The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation. J Nephrol. 2004;17(6):819.","journal-title":"J Nephrol"},{"issue":"1","key":"1489_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/ndt\/gfi069","volume":"21","author":"M Gritters","year":"2006","unstructured":"Gritters M, Grooteman MP, Schoorl M, Schoorl M, Bartels PC, Scheffer PG, Teerlink T, Schalkwijk CG, Spreeuwenberg M, Nube MJ. Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant. 2006;21(1):153\u20139.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1489_CR13","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1744-9987.2011.00996.x","volume":"15","author":"K Tiranathanagul","year":"2011","unstructured":"Tiranathanagul K, Jearnsujitwimol O, Susantitaphong P, Kijkriengkraikul N, Leelahavanichkul A, Srisawat N, Praditpornsilpa K, Eiam-Ong S. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration. Ther Apher Dial. 2011;15(6):556\u201364.","journal-title":"Ther Apher Dial"},{"key":"1489_CR14","doi-asserted-by":"publisher","first-page":"101057","DOI":"10.1016\/j.redox.2018.11.015","volume":"21","author":"X Wu","year":"2019","unstructured":"Wu X, Dai H, Liu L, Xu C, Yin Y, Yi J, Bielec MD, Han Y, Li S. Citrate reduced oxidative damage in stem cells by regulating cellular redox signaling pathways and represent a potential treatment for oxidative stress-induced diseases. Redox Biol. 2019;21:101057.","journal-title":"Redox Biol"},{"issue":"1","key":"1489_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1880-1","volume":"21","author":"AG Schneider","year":"2017","unstructured":"Schneider AG, Journois D, Rimmel\u00e9 T. Complications of regional citrate anticoagulation: accumulation or overload? Crit Care. 2017;21(1):1\u20137.","journal-title":"Crit Care"},{"issue":"2","key":"1489_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jcrc.2013.10.015","volume":"29","author":"D Khadzhynov","year":"2014","unstructured":"Khadzhynov D, Schelter C, Lieker I, Mika A, Staeck O, Neumayer H-H, Peters H, Slowinski T. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation. J Crit Care. 2014;29(2):265\u201371.","journal-title":"J Crit Care"},{"issue":"1","key":"1489_CR17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12882-019-1648-8","volume":"20","author":"I Lenga","year":"2019","unstructured":"Lenga I, Hopman WM, O\u2019Connell AJ, Hume F, Wei CC. Flexitrate regional citrate anticoagulation in continuous venovenous hemodiafiltration: a retrospective analysis. BMC Nephrol. 2019;20(1):452.","journal-title":"BMC Nephrol"},{"issue":"9","key":"1489_CR18","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1007\/s00134-014-3406-5","volume":"40","author":"MM Ghassemi","year":"2014","unstructured":"Ghassemi MM, Richter SE, Eche IM, Chen TW, Danziger J, Celi LA. A data-driven approach to optimized medication dosing: a focus on heparin. Intensive Care Med. 2014;40(9):1332\u20139.","journal-title":"Intensive Care Med"},{"issue":"6","key":"1489_CR19","doi-asserted-by":"publisher","first-page":"e17648","DOI":"10.2196\/17648","volume":"8","author":"L Su","year":"2020","unstructured":"Su L, Liu C, Li D, He J, Zheng F, Jiang H, Wang H, Gong M, Hong N, Zhu W. Toward optimal heparin dosing by comparing multiple machine learning methods: retrospective study. JMIR Med Inform. 2020;8(6):e17648.","journal-title":"JMIR Med Inform"},{"issue":"1","key":"1489_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.21500\/20112084.844","volume":"3","author":"D Cousineau","year":"2010","unstructured":"Cousineau D, Chartier S. Outliers detection and treatment: a review. Int J Psychol Res. 2010;3(1):58\u201367.","journal-title":"Int J Psychol Res"},{"issue":"4","key":"1489_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ipm.2009.03.002","volume":"45","author":"M Sokolova","year":"2009","unstructured":"Sokolova M, Lapalme G. A systematic analysis of performance measures for classification tasks. Inf Process Manag. 2009;45(4):427\u201337.","journal-title":"Inf Process Manag"},{"issue":"3","key":"1489_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.4310\/SII.2009.v2.n3.a8","volume":"2","author":"T Hastie","year":"2009","unstructured":"Hastie T, Rosset S, Zhu J, Zou H. Multi-class adaboost. Stat Interface. 2009;2(3):349\u201360.","journal-title":"Stat Interface"},{"key":"1489_CR23","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. Xgboost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD international conference on knowledge discovery and data mining: 2016; 2016:785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"1489_CR24","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511801389","volume-title":"An introduction to support vector machines and other kernel-based learning methods","author":"N Cristianini","year":"2000","unstructured":"Cristianini N, Shawe-Taylor J. An introduction to support vector machines and other kernel-based learning methods. Cambridge: Cambridge University Press; 2000."}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-021-01489-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-021-01489-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:52:00Z","timestamp":1672959120000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-021-01489-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":24,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1489"],"URL":"https:\/\/doi.org\/10.1186\/s12911-021-01489-8","relation":{},"ISSN":["1472-6947"],"issn-type":[{"type":"electronic","value":"1472-6947"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The application of retrospective data was approved by the Ethics Committee of Peking Union Medical College Hospital, and all study data were used with the authorization and informed consent of patients or their families.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors provide consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"126"}}